Clinical Trial

VitaFlow™ Transcatheter Aortic Valve System Post-market Study-The LAUNCH Study

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 4, 2020 (before its estimated December 1, 2021 completion). Its status may not reflect the trial's current state.
Summary
The study objective is to evaluate safety and effectiveness/performance of the Microport™ CardioFlow VitaFlow™ Transcatheter Aortic Valve System for the treatment of severe aortic stenosis in the real world settings.
Trial Details
NCT Number NCT04414865
Lead Sponsor Shanghai MicroPort CardioFlow Medtech Co., Ltd.
Conditions Aortic Valve Stenosis
Enrollment 100 participants
Start Date 2020-04-26
Primary Completion 2021-12-01 (estimated)
Study Completion 2027-12-30 (estimated)
Updated on ClinicalTrials.gov 2020-06-04